Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects

Trial Profile

Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jan 2015

At a glance

  • Drugs Sufentanil (Primary) ; Sufentanil (Primary)
  • Indications Acute pain; Cancer pain; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors AcelRx Pharmaceuticals
  • Most Recent Events

    • 14 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 May 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top